101 results
424B3
CYDY
CytoDyn Inc.
29 Jan 24
Prospectus supplement
5:22pm
short- and long-term incentive plans in which other executive officers may participate, including an target annual bonus of 40% of his base salary … no obligation to adjust the Base Salary at any time.
(b)Annual Bonus. For each fiscal year ending during the Term (beginning with the fiscal year
8-K
EX-10.1
CYDY
CytoDyn Inc.
29 Jan 24
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
8:40am
time.
(b)Annual Bonus. For each fiscal year ending during the Term (beginning with the fiscal year ending May 31, 2024), the Executive shall … be eligible to receive an annual bonus (the “Annual Bonus”) with a target amount as determined by the Compensation Committee annually (the “Target Annual
8-K
CYDY
CytoDyn Inc.
29 Jan 24
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
8:40am
plans in which other executive officers may participate, including an target annual bonus of 40% of his base salary earned for services in the fiscal
424B3
CYDY
CytoDyn Inc.
22 Nov 23
Prospectus supplement
12:16pm
. The Employment Agreement does not provide for the payment of cash bonus or equity compensation or severance benefits.
Item 7.01 Regulation FD … in this Agreement, the term “Base Salary” shall refer to Base Salary as may be adjusted from time to time.
Annual Bonus. The Executive has elected
8-K
2z2366 eyhvxrs
21 Nov 23
CytoDyn Appoints Jacob Lalezari M.D. as Interim CEO
5:15pm
8-K
EX-10.1
gl2e bibsg
21 Nov 23
CytoDyn Appoints Jacob Lalezari M.D. as Interim CEO
5:15pm
424B3
2ha2i2m
24 Oct 23
Prospectus supplement
6:01am
424B3
efz3vh0rlv83n0d35
10 Oct 23
Prospectus supplement
6:02pm
POS AM
2fbbyeedmbaztc
2 Oct 23
Prospectus update (post-effective amendment)
5:15pm
424B3
ch3 20msjltq649z
11 Jul 23
Prospectus supplement
5:28pm
8-K
2m5qjy2m
30 Jun 22
Unregistered Sales of Equity Securities
4:24pm